A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Placebo-Controlled Trial of Glycine Added to Clozapine in Schizophrenia
2000
American Journal of Psychiatry
Objective: The purpose of this study was to evaluate the effects of high-dose oral glycine on positive and negative symptoms and cognitive function when added to clozapine in adults with schizophrenia. Method: The authors conducted a double-blind, placebocontrolled, parallel-group trial of 60 g/day of glycine added to clozapine for 8 weeks in 30 adults with schizophrenia. Clinical ratings were performed every 2 weeks. Results: Twenty-seven patients completed the trial. Glycine augmentation of
doi:10.1176/appi.ajp.157.5.826
pmid:10784481
fatcat:rtk7nixdgrf73aixaox77ikoxa